Combining Enzalutamide with Radium-223 Significantly Improves rPFS as First-Line Therapy for Patients with mCRPC By Ogkologos - August 27, 2025 332 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACE-3 study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical Form Along with a New Route of Administration FDA Approves Pembrolizumab and Berahyaluronidase alfa-pmph for Subcutaneous Injection Study presents an AI-guided approach to target cancer antigens MOST POPULAR Woman Perfectly Breaks Down Grief Using ‘Ball In The Box’ Analogy... March 8, 2019 Foodie Fridays-Gazpacho: A Favorite Summer Soup August 6, 2021 Cancer in My Community: Overcoming Inequities in Care in Argentina January 3, 2023 GPRC5D Is An Active Immunotherapeutic Target in Multiple Myeloma October 5, 2022 Load more HOT NEWS Making Cancer Care More Equitable: A Cancer Survivor’s Story Chaunté Lowe Has Competed In 4 Olympic Games, And Isn’t Letting... For Early-Stage Lung Cancer, Study Identifies Potential New Biomarker, Treatment Target Mosunetuzumab Plus Polatuzumab Vedotin Shows Promise for Patients with Aggressive Relapsed...
